Novavax, Inc. (NVAX)

10.46 -0.14 (-1.32%) USD  |  NASDAQ  |  Oct 02, 16:00
10.44 -0.02 (-0.19%) After-Hours: 20:00
More

Novavax EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for NVAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS LT Growth Estimates Data

View and export this data back to 2026. Start Trial.
Date Value
August 07, 2026 --
May 06, 2026 --
Date Value
April 08, 2026 --
February 27, 2026 --

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Merck & Co., Inc. Upgrade
Pfizer Inc. Upgrade
Agenus, Inc. --
Editas Medicine, Inc. --
Recursion Pharmaceuticals, Inc. --